UBS O'Connor is operates as an investment management company within UBS Asset Management.
UBS O'Connor LLC operates as an investment management company. The Company offers wealth management, hedge and mutual funds, capital market, asset allocation, real estate, fixed income, investment strategies, risk control, and financial planning services.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 12, 2022
Logix Fibre Networks
|
Series Unknown | $100M | Communications Infrastructure | Yes |
May 5, 2022
Voyage Foods
|
Series A | $36M | Consumer Goods | Yes |
Mar 1, 2022
LumiraDx
|
Post-IPO Debt | $56.50M | Health Care | Yes |
Nov 4, 2021
Lime
|
Debt Financing | $105M | Last Mile Transportation | Yes |
Sep 20, 2021
GOOD Meat
|
Series Unknown | $97M | Food and Beverage | — |
UBS O'Connor has had 7 exits. UBS O'Connor most notable exits include LumiraDx , Humacyte
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Sep 29, 2021 | LumiraDx | IPO | Health Care | Detail |
Aug 27, 2021 | Humacyte | IPO | Biotechnology | Detail |
Aug 12, 2021 | Rockley Photonics | IPO | Consumer Electronics | Detail |
Jul 19, 2021 | Evolv Technology | IPO | Artificial Intelligence | Detail |
Apr 7, 2021 | AST SpaceMobile | IPO | Information Technology | Detail |